Insider · CIK 0001277503

KANEKO YASUNORI

Reports to the SEC for 13 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001277503

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+5,700 sh	—	—	25,700
2026-06-11	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.9K sh	—	—	16,900
2025-06-10	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+13.3K sh	—	—	33,300
2025-06-10	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38.3K sh	—	—	38,300
2025-02-27	RCUSArcus Biosciences, Inc.P Purchase	Director	PPurchase	+20K sh	$10.06	+$201K	28,400
2024-06-06	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+8,400 sh	—	—	15,200
2024-06-06	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2023-06-15	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+6,800 sh	—	—	6,800
2023-06-15	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2022-06-14	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+4,100 sh	—	—	4,100
2022-06-14	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2021-06-03	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+3,000 sh	—	—	6,000
2021-06-03	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2021-04-23	RCUSArcus Biosciences, Inc.P Purchase	Director	PPurchase	+4,133 sh	$31.37	+$130K	7,133
2020-06-05	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35K sh	$7.99	+$280K	38,000
2020-06-05	RCUSArcus Biosciences, Inc. · Stock Option (Rights to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−35K sh	—	—	0
2020-06-04	RCUSArcus Biosciences, Inc.A Award	Director	AAward	+3,000 sh	—	—	3,000
2020-06-04	RCUSArcus Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2019-06-06	RCUSArcus Biosciences, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-03-19	RCUSArcus Biosciences, Inc.C Conversion	Director	CConversion	+505K sh	—	—	505,050
2018-03-19	RCUSArcus Biosciences, Inc.C Conversion	Director	CConversion	+253K sh	—	—	252,524
2018-03-19	RCUSArcus Biosciences, Inc.C Conversion	Director	CConversion	+33.8K sh	—	—	96,948
2018-03-19	RCUSArcus Biosciences, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−505K sh	—	—	0
2018-03-19	RCUSArcus Biosciences, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−253K sh	—	—	0
2018-03-19	RCUSArcus Biosciences, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−31.3K sh	—	—	0
2018-03-19	RCUSArcus Biosciences, Inc. · Series C Convertible Preferred StockC Conversion	Director	CConversion	−2,565 sh	—	—	0
2017-12-05	COLLCOLLEGIUM PHARMACEUTICAL, INCJ Other	10% Owner	JOther	−800K sh	—	—	2,149,916
2017-12-05	COLLCOLLEGIUM PHARMACEUTICAL, INCJ Other	10% Owner	JOther	+270 sh	—	—	270
2006-01-16	RENOVIS INCStock Option (Right to buy)A Award	Former Director	AAward	+11.1K sh	—	—	11,111
2005-02-09	RENOVIS INCStock Opton (Right to buy)A Award	Former Director	AAward	+11.1K sh	—	—	11,111
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+38.6K sh	—	—	38,611
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+450K sh	—	—	449,788
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+27.8K sh	—	—	27,811
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+324K sh	—	—	323,977
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+135K sh	—	—	135,303
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+8,156 sh	—	—	8,156
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+95K sh	—	—	95,018
2004-02-10	RENOVIS INCC Conversion	Former Director	CConversion	+198K sh	—	—	198,412
2004-02-10	RENOVIS INCSeries B Preferred StockC Conversion	Former Director	CConversion	−158K sh	—	—	0
2004-02-10	RENOVIS INCSeries B Preferred StockC Conversion	Former Director	CConversion	−1.84M sh	—	—	0
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	Former Director	CConversion	−103K sh	—	—	0
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	Former Director	CConversion	−1.2M sh	—	—	0
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	Former Director	CConversion	−500K sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	Former Director	CConversion	−36.7K sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	Former Director	CConversion	−428K sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	Former Director	CConversion	−893K sh	—	—	0

Recent filings

Accepted (ET)
Jun 124
KANEKO YASUNORI0001277503-26-000003
SEC(opens sec.gov)
Jun 124
KANEKO YASUNORI0001724521-25-000087
SEC(opens sec.gov)
Feb 274
KANEKO YASUNORI0001724521-25-000046
SEC(opens sec.gov)
Jun 74
KANEKO YASUNORI0001724521-24-000116
SEC(opens sec.gov)
Jun 164
KANEKO YASUNORI0001209191-23-038141
SEC(opens sec.gov)
Jun 164
KANEKO YASUNORI0001209191-22-037409
SEC(opens sec.gov)
Jun 74
KANEKO YASUNORI0001209191-21-038619
SEC(opens sec.gov)
Apr 264
KANEKO YASUNORI0001179110-21-004605
SEC(opens sec.gov)
Jun 84
KANEKO YASUNORI0001209191-20-034985
SEC(opens sec.gov)
Jun 104
KANEKO YASUNORI0001209191-19-035752
SEC(opens sec.gov)
Mar 194
KANEKO YASUNORI0000899243-18-007986
SEC(opens sec.gov)

Companies

Address

C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY

HAYWARD, CA, 94545